Ergoteles’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,672
Closed -$939K 466
2023
Q2
$939K Buy
+5,672
New +$915K 0.05% 480
2022
Q4
Sell
-78,671
Closed -$12.9M 1672
2022
Q3
$12.9M Buy
+78,671
New +$13.3M 0.45% 30
2021
Q4
Sell
-1,247
Closed -$201K 1417
2021
Q3
$201K Sell
1,247
-133,203
-99% -$22.7M 0.01% 1000
2021
Q2
$22.1M Buy
+134,450
New +$22.3M 0.51% 32
2021
Q1
Sell
-172,871
Closed -$27.2M 931
2020
Q4
$27.2M Buy
172,871
+123,871
+253% +$18.3M 0.9% 20
2020
Q3
$7.29M Buy
+49,000
New +$7.25M 0.97% 25

Other funds holding JNJ

Ergoteles's JNJ Position: Q3 2023 in Review

Ergoteles sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 5,672 shares — an estimated $939K sold.

Ergoteles first reported a position in JNJ in Q3 2020 and held it in 6 quarters. The position peaked at $27.2M in Q4 2020. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Ergoteles reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 5,672 Johnson & Johnson shares in Q3 2023, an estimated $939K.
  • Ergoteles first reported a position in Johnson & Johnson in Q3 2020 and held it in 6 quarters.
  • Ergoteles's Johnson & Johnson position peaked at $27.2M in Q4 2020.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.